Literature DB >> 20970663

Validation of xCELLigence real-time cell analyzer to assess compatibility in xenotransplantation with pig-to-baboon model.

J J Quereda1, L Martínez-Alarcón, L Mendoça, M J Majado, J M Herrero-Medrano, F J Pallarés, A Ríos, P Ramírez, A Muñoz, G Ramis.   

Abstract

OBJECTIVE: To validate the use of a microelectronic real-time cell analyzer system (RTCA) we developed a complement-mediated antibody cytotoxicity assay to investigate the compatibility of a graft and a recipient in pig-to-baboon xenotransplantation.
MATERIALS AND METHODS: Fibroblasts isolated from the skin of five hCD55, hCD59, and hCD46 transgenic pigs (TP) were cultured in 96 microelectronic well plates for 17 hours. Then, we added to each microwell 20 μL of normal sera from nine healthy adult olive baboons (Papio anubis)-three males and six females. The evolution of the cell culture was assessed every 3 minutes during the pretreatment period, at 11 hours postaddition, and every 30 minutes from 12 to 96 hours. Simultaneously, we performed a 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Fibroblasts from wild-type (WT) pigs were used as positive controls and microwells without serum addition from each TP as negative controls. The RTCA results were expressed as a normalized cellular index (NCI).
RESULTS: Differences were observed between the five TP fibroblasts and the WT fibroblasts, with greater cytotoxicity on WT cells. Among TP, a higher cytolytic level was observed in males than females. The MTT results correlated with NCI at different times, with the minimum NCI and with the time to for NCI recovery before serum addition. The correlation was lower than that previously reported in environmental toxicity assays.
CONCLUSIONS: RTCA allows a long-term assessment of the immunocytotoxic effect of baboon sera on pig cells, providing a suitable tool to perform compatibility tests for xenotransplantation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970663     DOI: 10.1016/j.transproceed.2010.05.059

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cells.

Authors:  Andrew G MacLean; Edith Walker; Gautam K Sahu; Gail Skowron; Preston Marx; Dorothee von Laer; Richard P Junghans; Stephen E Braun
Journal:  J Med Primatol       Date:  2014-08-20       Impact factor: 0.667

2.  Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach.

Authors:  Hamanou Benachour; Thierry Bastogne; Magali Toussaint; Yosra Chemli; Aymeric Sève; Céline Frochot; François Lux; Olivier Tillement; Régis Vanderesse; Muriel Barberi-Heyob
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

3.  Time-resolved human kinome RNAi screen identifies a network regulating mitotic-events as early regulators of cell proliferation.

Authors:  Jitao David Zhang; Cindy Koerner; Stephanie Bechtel; Christian Bender; Ioanna Keklikoglou; Christian Schmidt; Anja Irsigler; Ute Ernst; Ozgür Sahin; Stefan Wiemann; Ulrich Tschulena
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

4.  Label-Free Monitoring of Uptake and Toxicity of Endoprosthetic Wear Particles in Human Cell Cultures.

Authors:  Anika Jonitz-Heincke; Jenny Tillmann; Melanie Ostermann; Armin Springer; Rainer Bader; Paul Johan Hol; Mihaela R Cimpan
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

5.  Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI.

Authors:  Hamanou Benachour; Aymeric Sève; Thierry Bastogne; Céline Frochot; Régis Vanderesse; Jordane Jasniewski; Imen Miladi; Claire Billotey; Olivier Tillement; François Lux; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2012-09-29       Impact factor: 11.556

6.  Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines.

Authors:  Melissa A Vetten; Nonhlanhla Tlotleng; Delia Tanner Rascher; Amanda Skepu; Frankline K Keter; Kailen Boodhia; Leigh-Anne Koekemoer; Charlene Andraos; Robert Tshikhudo; Mary Gulumian
Journal:  Part Fibre Toxicol       Date:  2013-10-09       Impact factor: 9.400

7.  Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes.

Authors:  Ke Peng; Yun Qiu; Jian Li; Zhao-Cai Zhang; Fu-Hai Ji
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.